Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Hodgkin's Lymphoma Refractory/Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03528421
What this trial is testing

Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients

Who this might be right for
Non Hodgkin Lymphoma
Beijing Immunochina Medical Science & Technology Co., Ltd. 30
Early research (Phase 1)Active Not RecruitingNCT06470438
What this trial is testing

JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinRefractory B-Cell NHLRelapsed B-cell NHL
Janssen Research & Development, LLC 58
Early research (Phase 1)Study completedNCT00621452
What this trial is testing

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+8 more
Fred Hutchinson Cancer Center 12
Early research (Phase 1)Study completedNCT00709033
What this trial is testing

T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Baylor College of Medicine 3
Early research (Phase 1)WithdrawnNCT00004114
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00933985
What this trial is testing

Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia

Who this might be right for
Acute Leukemias of Ambiguous LineageAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+26 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT03039114
What this trial is testing

Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)

Who this might be right for
Lymphoma
Incyte Corporation 26
Testing effectiveness (Phase 2)Study completedNCT00054808
What this trial is testing

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaRelapsed LymphomaRefractory Lymphoma+2 more
Genta Incorporated 40
Not applicableNo Longer AvailableNCT06331832
What this trial is testing

Expanded Access of Imvotamab (IGM-2323) in Patients With R/R NHL

Who this might be right for
Relapsed/Refractory Non-Hodgkin Lymphomas
IGM Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01300026
What this trial is testing

AMG 319 Lymphoid Malignancy FIH

Who this might be right for
CancerChronic Lymphocytic LeukemiaDiffuse Large Cell Lymphoma+11 more
Amgen 28
Testing effectiveness (Phase 2)Study completedNCT00086944
What this trial is testing

Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 25
Post-approval studies (Phase 4)Study completedNCT01990534
What this trial is testing

Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Millennium Pharmaceuticals, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT05574114
What this trial is testing

Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

Who this might be right for
Non-Hodgkin LymphomaNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT03409432
What this trial is testing

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
Lymphomatoid PapulosisPrimary Cutaneous Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more
John Reneau 26
Not applicableLooking for participantsNCT07059741
What this trial is testing

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06768905
What this trial is testing

IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma
University of Texas Southwestern Medical Center 30
Early research (Phase 1)Looking for participantsNCT07283796
What this trial is testing

Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
NHL
Haisco Pharmaceutical Group Co., Ltd. 110
Early research (Phase 1)UnknownNCT04356846
What this trial is testing

A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
The First Affiliated Hospital with Nanjing Medical University 74
Early research (Phase 1)Looking for participantsNCT06445803
What this trial is testing

CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed RemissionB-cell Lymphoma Refractory+1 more
Rong Tao 48
Next Page